SECTOR:
Diagnostics/tools
FUND/VEHICLE:
NFLS Direct Investment
INVESTMENT DATE:
2017
GEOGRAPHY:
North America
STATUS CURRENT/FORMER INVESTMENT:
Existing
WEBSITE:
Grail is a diagnostics company formed by Illumina. The company is developing and commercializing a blood test for asymptomatic cancer screening via detection of circulating tumor DNA.